Drug Profile
Research programme: metabolic disorder therapeutics - Johnson and Johnson Innovation/Zhejiang University
Alternative Names: GPR81 modulators - Johnson and Johnson Innovation/Zhejiang UniversityLatest Information Update: 28 Nov 2018
Price :
$50
*
At a glance
- Originator Johnson & Johnson Innovation; Zhejiang University
- Developer Johnson & Johnson Innovation
- Class
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diabetes mellitus; Dyslipidaemias; Obesity
Most Recent Events
- 28 Nov 2018 No recent reports of development identified for research development in Diabetes-mellitus in China
- 28 Nov 2018 No recent reports of development identified for research development in Dyslipidaemias in China
- 28 Nov 2018 No recent reports of development identified for research development in Obesity in China